Remote Assessment of Disease and Relapse in Central Nervous System Disorders (RADAR-CNS) is a major international research project. It aims to develop new ways of measuring major depressive disorder, epilepsy and multiple sclerosis (MS) using wearable devices and smartphone technology.
RADAR-CNS aims to improve people’s quality of life and change how depression, epilepsy and MS are managed and treated. Data from mobile devices can give a full picture of a person’s condition at a level of detail which was previously impossible. This offers the potential to detect changes in behaviour, sleep, or mood before the individual themselves is aware of it. This could help them to predict – or even avoid – a relapse.
RADAR-CNS brings together clinicians, researchers, engineers, computer scientists and bioinformaticians from all over the world. It is jointly led by King’s College London and Janssen Pharmaceutica NV. The project is funded by the Innovative Medicines Initiative — a Public Private Partnership set up between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union). It includes 23 organisations from across Europe and the US.
For Further information visit: https://www.radar-cns.org/
RADAR-CNS on Twitter: https://twitter.com/RADARCNS